Flow mediated dilatation in systemic sclerosis: Effects of iloprost treatment

被引：0
|
作者：
Giannattasio, C
Gentile, G
Failla, M
Pozzi, M
Gardinali, M
Meles, E
Zazzeron, C
Fantini, E
Maestroni, S
Mancia, G
机构：
[1] Clin Med Bicocca Univ, S Gerardo H, Monza, Italy
[2] S Gerardo H, Div Med 2, Monza, Italy
[3] Ist Interuniv Fisiol Clin Ipertens, Milan, Italy
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [31] INFUSION OF ILOPROST, A PROSTACYCLIN ANALOG, FOR TREATMENT OF RAYNAUDS-PHENOMENON IN SYSTEMIC-SCLEROSIS
    MCHUGH, NJ
    CSUKA, M
    WATSON, H
    BELCHER, G
    AMADI, A
    RING, EFJ
    BLACK, CM
    MADDISON, PJ
    ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (01) : 43 - 47
  • [32] Diffuse cutaneous systemic sclerosis treated with intravenous iloprost
    Foti, C
    Cassano, N
    Conserva, A
    Coviello, C
    De Meo, M
    Vena, GA
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (03) : 321 - 323
  • [33] Safety and Persistence of Monthly Intravenous Iloprost in Systemic Sclerosis
    Martins, Patricia
    Dourado, Eduardo
    Fonseca, Joao Eurico
    Romao, Vasco C.
    Resende, Catarina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 814 - 816
  • [34] EFFECTS OF ILOPROST ON T-LYMPHOCYTE ACTIVATION PATHWAY IN EARLY SYSTEMIC SCLEROSIS (ESSC)
    Faggioli, P.
    Gatti, A.
    Mazzone, A.
    Sciascera, A.
    Brando, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S122 - S122
  • [35] Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis
    Alexandra Balbir-Gurman
    Yolanda Braun-Moscovici
    Vladimir Livshitz
    Daniel Schapira
    Doron Markovits
    Alexander Rozin
    Tatiana Boikaner
    A. Menahem Nahir
    Clinical Rheumatology, 2007, 26 : 1517 - 1521
  • [36] Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis
    Trombetta, Amelia Chiara
    Pizzorni, Carmen
    Ruaro, Barbara
    Paolino, Sabrina
    Sulli, Alberto
    Smith, Vanessa
    Cutolo, Maurizio
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (11) : 2033 - 2041
  • [37] INTRAVENOUS ILOPROST TREATMENT OF RAYNAUDS-PHENOMENON AND ISCHEMIC ULCERS SECONDARY TO SYSTEMIC-SCLEROSIS
    WIGLEY, FM
    SEIBOLD, JR
    WISE, RA
    MCCLOSKEY, DA
    DOLE, WP
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (09) : 1407 - 1414
  • [38] Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis
    Balbir-Gurman, Alexandra
    Braun-Moscovici, Yolanda
    Livshitz, Vladimir
    Schapira, Daniel
    Markovits, Doron
    Rozin, Alexander
    Boikaner, Tatiana
    Nahir, A. Menahem
    CLINICAL RHEUMATOLOGY, 2007, 26 (09) : 1517 - 1521
  • [39] Iloprost infusion does not reduce oxidative stress in systemic sclerosis
    Alessandro Volpe
    Domenico Biasi
    Paola Caramaschi
    Lisa Maria Bambara
    Antonio Carletto
    Maurizio Degan
    Pietro Minuz
    Rheumatology International, 2008, 28 : 335 - 337
  • [40] PROLONGED INCREASE IN DIGITAL BLOOD-FLOW FOLLOWING ILOPROST INFUSION IN PATIENTS WITH SYSTEMIC-SCLEROSIS
    RADEMAKER, M
    THOMAS, RHM
    PROVOST, G
    BEACHAM, JA
    COOKE, ED
    KIRBY, JD
    POSTGRADUATE MEDICAL JOURNAL, 1987, 63 (742) : 617 - 620
12345